Timothy P Clackson insider trades: Theseus Pharmaceuticals (THRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
43 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | THRX | ↑ Buy | 2,500 | $6.80 | $17K | Direct | Nov 14, 2022 (3d) |
| Dec 21, 2021 | THRX | ↑ Buy | 2,600 | $9.76 | $25K | Direct | Dec 22, 2021 (1d) |
| Oct 24, 2016 | ARIA | ↓ Sell | 19,638 | $9.56 | $188K | Direct | Oct 25, 2016 (1d) |
| Sep 28, 2016 | ARIA | ↓ Sell10b5-1 | 8,750 | $13.98 | $122K | Direct | Sep 28, 2016 (0d) |
| Sep 22, 2016 | ARIA | ↓ Sell | 20,000 | $13.43 | $269K | Direct | Sep 23, 2016 (1d) |
| Sep 15, 2016 | ARIA | ↓ Sell | 59,369 | $11.73 | $696K | Direct | Sep 16, 2016 (1d) |
| Aug 22, 2016 | ARIA | ↓ Sell | 19,436 | $10.47 | $204K | Direct | Aug 23, 2016 (1d) |
| Aug 12, 2016 | ARIA | ↓ Sell10b5-1 | 25,000 | $10.50 | $263K | Direct | Aug 15, 2016 (3d) |
| Jul 22, 2016 | ARIA | ↓ Sell | 18,286 | $8.11 | $148K | Direct | Jul 25, 2016 (3d) |
| Jul 1, 2016 | ARIA | ↓ Sell | 61,422 | $7.48 | $460K | Direct | Jul 5, 2016 (4d) |
| Jun 22, 2016 | ARIA | ↓ Sell10b5-1 | 23,999 | $7.28 | $175K | Direct | Jun 23, 2016 (1d) |
| May 23, 2016 | ARIA | ↓ Sell | 17,762 | $8.08 | $143K | Direct | May 25, 2016 (2d) |
| May 2, 2016 | ARIA | ↓ Sell | 11,700 | $7.13 | $83K | Direct | May 2, 2016 (0d) |
| Apr 22, 2016 | ARIA | ↓ Sell | 21,409 | $7.37 | $158K | Direct | Apr 25, 2016 (3d) |
| Mar 22, 2016 | ARIA | ↓ Sell | 23,834 | $6.58 | $157K | Direct | Mar 23, 2016 (1d) |
| Mar 19, 2016 | ARIA | ↓ Sell | 5,417 | $6.47 | $35K | Direct | Mar 22, 2016 (3d) |
| Mar 3, 2016 | ARIA | ↓ Sell | 34,672 | $6.03 | $209K | Direct | Mar 3, 2016 (0d) |
| Feb 1, 2016 | ARIA | ↓ Sell | 14,667 | $4.81 | $71K | Direct | Feb 3, 2016 (2d) |
| Sep 28, 2015 | ARIA | ↓ Sell | 8,750 | $6.46 | $57K | Direct | Sep 28, 2015 (0d) |
| Jul 16, 2015 | ARIA | ↓ Sell | 7,000 | $8.54 | $60K | Direct | Jul 16, 2015 (0d) |
| Apr 23, 2015 | ARIA | ↓ Sell | 123,766 | $9.50 | $1.2M | Direct | Apr 27, 2015 (4d) |
| Mar 23, 2015 | ARIA | ↓ Sell10b5-1 | 32,741 | $8.88 | $291K | Direct | Mar 23, 2015 (0d) |
| Feb 20, 2015 | ARIA | ↓ Sell | 49,035 | $8.00 | $392K | Direct | Feb 24, 2015 (4d) |
| Feb 2, 2015 | ARIA | ↓ Sell10b5-1 | 14,667 | $6.33 | $93K | Direct | Feb 4, 2015 (2d) |
| Apr 2, 2014 | ARIA | ↓ Sell10b5-1 | 6,500 | $8.21 | $53K | Direct | Apr 3, 2014 (1d) |
| Mar 21, 2014 | ARIA | ↓ Sell10b5-1 | 6,667 | $7.89 | $53K | Direct | Mar 21, 2014 (0d) |
| Dec 19, 2013 | ARIA | ↓ Sell10b5-1 | 9,750 | $5.14 | $50K | Direct | Dec 20, 2013 (1d) |
| Sep 6, 2013 | ARIA | ↓ Sell | 8,449 | $22.00 | $186K | Direct | Sep 10, 2013 (4d) |
| Jul 18, 2013 | ARIA | ↓ Sell | 14,000 | $19.79 | $277K | Direct | Jul 18, 2013 (0d) |
| Apr 2, 2013 | ARIA | ↓ Sell | 6,500 | $18.04 | $117K | Direct | Apr 3, 2013 (1d) |
| Mar 25, 2013 | ARIA | ↓ Sell | 19,167 | $18.87 | $362K | Direct | Mar 26, 2013 (1d) |
| Mar 22, 2013 | ARIA | ↓ Sell | 6,667 | $19.46 | $130K | Direct | Mar 22, 2013 (0d) |
| Mar 4, 2013 | ARIA | ↓ Sell | 9,838 | $21.00 | $207K | Direct | Mar 5, 2013 (1d) |
| Aug 15, 2012 | ARIA | ↓ Sell | 36,843 | $20.00 | $737K | Direct | Aug 16, 2012 (1d) |
| Jul 30, 2012 | ARIA | ↓ Sell | 23,234 | $19.00 | $441K | Direct | Aug 1, 2012 (2d) |
| May 2, 2012 | ARIA | ↓ Sell | 20,000 | $17.00 | $340K | Direct | May 4, 2012 (2d) |
| Apr 17, 2012 | ARIA | ↓ Sell | 38,711 | $14.86 | $575K | Direct | Apr 17, 2012 (0d) |
| Apr 3, 2012 | ARIA | ↓ Sell | 31,261 | $16.31 | $510K | Direct | Apr 3, 2012 (0d) |
| Mar 26, 2012 | ARIA | ↓ Sell | 7,500 | $16.00 | $120K | Direct | Mar 28, 2012 (2d) |
| Mar 23, 2012 | ARIA | ↓ Sell | 15,333 | $15.41 | $236K | Direct | Mar 26, 2012 (3d) |
| Mar 20, 2012 | ARIA | ↓ Sell | 36,400 | $15.02 | $547K | Direct | Mar 21, 2012 (1d) |
| Feb 14, 2012 | ARIA | ↓ Sell | 76,436 | $15.12 | $1.2M | Direct | Feb 16, 2012 (2d) |
| Oct 26, 2010 | ARIA | ↑ Buy | 10,000 | $3.70 | $37K | Direct | Oct 27, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timothy P Clackson's insider trades
Timothy P Clackson is President and CEO at Theseus Pharmaceuticals (THRX). Since Oct 26, 2010, Timothy has reported 3 open-market purchases worth $79K and 40 sales worth $11.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
8 sales (10% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (40 filings), option exercises (40 filings), shares withheld for taxes (7 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every THRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.